Zyflo, Zileuton News

Lynne Faraone created this wall of inspiration in her Mentor home. She says hope especially helped her as she fought for a warning label on the asthma and allergy medication Singulair.

Reports of neuropsychiatric adverse effects from leukotriene modifiers have prompted the FDA to request label changes for these drugs.

This roundup includes the following brief clinical practice updates: The FDA is warning consumers to stop using three Zicam intranasal products.

The FDA has requested that warnings of mood changes and suicidal behavior be placed on the label of Singulair, which is also facing challenges over the validity of its patent.

The FDA's new requirement for tighter warnings on a range of asthma drugs will not come as a surprise to Dr.

The U.S. Food and Drug Administration provided further updated safety information on a class of asthma drugs known as leukotriene modifiers.

The FDA has provided further updated safety information on a class of asthma drugs known as leukotriene modifiers.

Merck & Company 's top-selling drug, the asthma medication Singulair, and similar medicines should come with a caution about reports of psychiatric problems in some patients, the Food and Drug Administration said.

Leukotriene Inhibitors: Montelukast , Zafirlukast , and Zileuton June 12, 2009 Audience: Pulmonology healthcare professionals FDA provided healthcare professionals with updated information on the original March 2008 early communication and January 2009 follow-up communication about the ongoing safety review for the leukotriene inhibitors, ...

The U.S. Food and Drug Administration on Friday requested that the makers of a class of asthma drugs called leukotriene receptor agonists place a "precaution" on the drugs' labeling, warning of the potential for neuropsychiatric events.

The U.S. Food and Drug Administration is now asking that makers of asthma drugs in a specific class of medications include a precaution in the labeling explaining that neuropsychiatric events have been reported in some patients taking these products a ruling that affects Cary-based Cornerstone Therapeutics .

A physician and researcher affiliated with The Jackson Laboratory in Bar Harbor says he may have identified a cure for the most common form of human leukemia.

In the battle against cancer, allies can come from unexpected sources. Research at The Jackson Laboratory has yielded a new approach to treating leukemia, one that targets leukemia-proliferating cells with drugs that are already on the market.

Shares of VIA Pharmaceuticals Inc. jumped 45 percent Friday after the company presented a Phase II subset analysis showing that VIA-2291 reduced unstable coronary plaques in patients with acute coronary syndrome.

Kids with severe asthma can breathe a lot easier than they could a decade ago. Thanks in large part to better medications , children with severe asthma are less likely to wheeze and suffer full-blown asthma ...

Craig Collard says company will pick its targets. View Larger CARY Cornerstone Biopharma 's acquisition of Massachusetts-based Critical Therapeutics delivered the Cary company its highest potential drug, but ...

FDA is continuing to study the potential mood and behavioral adverse events linked with drugs that influence the leukotriene pathway, such as montelukast, zafirlukast, and zileuton.

The U.S. Food and Drug Administration said a safety review has yet to find conclusive evidence of any link between certain asthma drugs and suicide.

On March 27, 2008, FDA announced that it was reviewing safety data that raised concerns about a possible association between the use of montelukast and behavior/mood changes, suicidality and suicide.

An ongoing U.S. Food and Drug Administration safety review of possible suicidal behavior among those taking asthma drugs has found no evidence of a link so far, agency officials said Tuesday.